Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18

Known as: Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine, Human Papillomavirus Quadrivalent (types 6, 11, 16 and 18) Vaccine Recombinant, Recombinant Human Papillomavirus (HPV) Quadrivalent Vaccine 
A non-infectious recombinant, quadrivalent vaccine prepared from the highly purified virus-like particles (VLPs) of the major capsid (L1) protein of… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
IMPORTANCE Case reports have suggested a link between human papillomavirus (HPV) vaccination and development of multiple… (More)
  • table 1
  • figure I
  • table 2
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND In clinical trials, vaccines against human papillomavirus (HPV) have been highly effective against HPV16- or HPV18… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
IMPORTANCE Global use of human papillomavirus (HPV) vaccines to prevent cervical cancer is impeded by cost. A 2-dose schedule for… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
OBJECTIVES To evaluate the immunogenicity and safety of GARDASIL, a quadrivalent human papillomavirus (HPV) vaccine, in patients… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
OBJECTIVES To determine the effect of human papillomavirus (HPV) quadrivalent vaccine on the risk of developing subsequent… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Background:Previous analyses from a randomised trial in women aged 24–45 years have shown the quadrivalent human papillomavirus… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2011
2011
BACKGROUND Prophylactic vaccination with a quadrivalent HPV (types 6, 11, 16, 18) vaccine (qHPV) has been shown to prevent… (More)
  • table 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2009
2009
OBJECTIVE To present a combined analysis of the pregnancy outcomes for women aged up to 45 years enrolled in five phase III… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND The duration of protection afforded by vaccines represents a critical test of their utility as public health… (More)
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Vulval and vaginal cancers among younger women are often related to infection with human papillomavirus (HPV). These… (More)
Is this relevant?